Can exposure to diesel fuel, Jet Propulsion 8 (JP8), Jet Propulsion 4 (JP-4), industrial solvents for cleaning grease, hydraulic fluid, oil, and exhaust fumes cause prolactinoma and hyperprolactinemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

There is no established direct causal link between exposure to diesel fuel, JP8, JP-4, industrial solvents, hydraulic fluid, oil, or exhaust fumes and the development of prolactinoma or hyperprolactinemia, as evidenced by the lack of conclusive scientific literature on this topic 1. Prolactinoma is a benign tumor of the pituitary gland that produces excess prolactin hormone, while hyperprolactinemia is the condition of having elevated prolactin levels in the blood. These conditions are typically caused by factors such as pituitary tumors, certain medications (particularly antipsychotics, some antidepressants, and anti-nausea drugs), hypothyroidism, kidney disease, or chest wall injuries. Some key points to consider in the diagnosis and management of prolactinomas include:

  • The use of cabergoline as first-line therapy for prolactinomas, even in the presence of visual disturbance and pituitary apoplexy, while carefully monitoring for any deterioration in vision, pituitary function, or general status 1.
  • The consideration of radiotherapy if surgery is not an option, with the main indication for radiotherapy being control of tumor growth, whereas normalization of prolactin levels is a secondary objective 1.
  • The importance of monitoring clinical and biochemical parameters, including serum prolactin levels, and performing regular imaging studies, such as MRI, to assess tumor size and response to treatment 1.
  • The potential for medication-induced hyperprolactinemia, which can be caused by various medications, including antipsychotics, antidepressants, and anti-nausea drugs, and the need to exclude confounding diseases, such as primary hypothyroidism, chronic kidney disease, and severe liver disease 1. If you're experiencing symptoms of hyperprolactinemia (such as irregular periods, galactorrhea, erectile dysfunction, or reduced libido) and have a history of chemical exposure, it's essential to consult with an endocrinologist who can properly evaluate your condition through blood tests and possibly imaging studies like MRI to determine the actual cause and appropriate treatment.

From the Research

Causes of Hyperprolactinemia and Prolactinoma

  • Hyperprolactinemia is characterized by increased production of prolactin, often leading to reproductive dysfunction and galactorrhea 2
  • Prolactinomas are the most common pituitary tumors and may cause male-factor infertility by producing hypogonadism 2
  • The diagnostic evaluation of hyperprolactinemia requires exclusion of other causes, such as pregnancy, primary hypothyroidism, numerous medications, and miscellaneous causes 2

Treatment of Hyperprolactinemia and Prolactinoma

  • The treatment of choice for nearly all patients with hyperprolactinemic disorders is medical, using dopamine agonists such as bromocriptine, pergolide, and cabergoline 2, 3
  • Cabergoline is the preferred treatment for micro- and macroprolactinomas due to its effectiveness in normalizing prolactin levels and reducing prolactinoma size, as well as its fewer side-effects compared to bromocriptine 4, 5

Exposure to Diesel Fuel, JP8, JP-4, Industrial Solvents, and Exhaust Fumes

  • There is no direct evidence in the provided studies to suggest that exposure to diesel fuel, JP8, JP-4, industrial solvents, hydraulic fluid, oil, and exhaust fumes can cause prolactinoma and hyperprolactinemia 2, 3, 4, 6, 5
  • The studies focus on the diagnosis, treatment, and management of hyperprolactinemia and prolactinoma, but do not discuss the potential effects of environmental or occupational exposures on these conditions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyperprolactinemia.

International journal of fertility and women's medicine, 1999

Research

Drug treatment of hyperprolactinemia.

Annales d'endocrinologie, 2007

Research

Hyperprolactinemia: pathophysiology and management.

Treatments in endocrinology, 2003

Research

Hyperprolactinemia and prolactinoma.

Handbook of clinical neurology, 2014

Research

[Current diagnosis and treatment of hyperprolactinemia].

Revista medica del Instituto Mexicano del Seguro Social, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.